<DOC>
	<DOC>NCT01345942</DOC>
	<brief_summary>This open label, two period, crossover study will evaluate the safety and the effect of food on the pharmacokinetics of RO5428029 in healthy volunteers. In a crossover design, healthy subjects will be randomized to receive a single oral dose of RO5428029 with or without food, with a washout period of at least 7 days between dosing and a follow-up of 7 to 10 days after last dose. Anticipated time on study will be up to 21 days.</brief_summary>
	<brief_title>A Study on the Effect of Food on the Pharmacokinetics of RO5428029 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy volunteers, 18 to 60 years of age inclusive Body mass index (BMI) between 18 and 29.9 kg/m2, inclusive, and a minimum weight of 45 kg Female subjects must be surgically sterile or postmenopausal Male subjects and their partners of childbearing potential must use 2 methods of contraception (one of which a barrier method) for the duration of the study and for at least 70 days after the last dose Pregnant or lactating women, and male partners of women who are pregnant or lactating Women with reproductive potential History (within 3 months of screening) of alcohol consumption exceeding 2 standard units per day on average; alcohol consumption will be prohibited at least 48 hours before screening Positive test for drugs of abuse History or symptoms of any significant disease Positive for HIV, hepatitis B or hepatitis C infection Participation in an investigational drug or device study within 3 months prior to screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>